Continuous Glucose Monitoring (CGM) Devices Market Analysis by Components (Sensors, Transmitters, Receivers), by End User (Hospitals, In-House Setting), and by Region – Forecast to 2026
- Additional information
- Enquire about
Continuous Glucose Monitoring (CGM) Devices Market Analysis by Components (Sensors, Transmitters, Receivers), by End User (Hospitals, In-House Setting), and by Region - Forecast to 2026
The global continuous glucose monitoring (CGM) devices market size is expected to witness a CAGR of X.X% during the forecast period. Rising adoption of glucose monitoring devices owing to increasing incidences of diabetes are driving the global market growth. Moreover, the user-friendly & effective monitoring of glucose level, increasing technological advancements, digital penetration, and rising government initiatives spreading awareness are other drivers propelling the market growth. However, inadequate commercial availability and lack of technical know-how in remote locations are expected to restrain the growth.
Major companies in the continuous glucose monitoring devices market are F. Hoffmann-La Roche AG (Switzerland); Medtronic plc (Ireland); Abbott Laboratories (U.S.); DexCom, Inc. (U.S.); Johnson & Johnson (U.S.); Novo Nordisk A/S (Denmark); GlySens ICGM (U.S.); Ypsomed Holding (Switzerland); Boston Scientific Corporation (U.S.); and Becton, Dickinson and Company (U.S.). The leading players have adopted strategic collaborations, mergers & acquisitions, market expansion, and novel product development approaches to sustain in this competitive market.
This exhaustive research report focuses on market size and forecast at global, segmental, regional and country-level along with key market trends and dynamics from 2017 to 2026. The continuous glucose monitoring devices market report is categorized into the following segments and subsegments:
Continuous Glucose Monitoring Devices Market, By Components (Revenue, 2017-2026, USD Million)
Continuous Glucose Monitoring Devices Market, By End User (Revenue, 2017-2026, USD Million)
- In-House Settings
Continuous Glucose Monitoring Devices Market, By Region (Revenue, 2017-2026, USD Million)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- South Africa
- Saudi Arabia
- Rest of MEA
Key questions addressed by the research report-
- What are the current market trends (2017 to 2020) and future market forecast from 2021 to 2026 for the market?
- What are the market dynamics and probable opportunities for market players during the forecast period?
- Initiatives undertaken my market players to address the COVID-19 impact to sustain in the competitive market.
- Which geographies have immense opportunities in different segments and sub-segments of the market?
- What are the recent strategies adopted by market players such as product launch, partnership, agreement, collaboration, merger & acquisition, and geographical expansion?